首頁(yè) 資訊 Mycophenolic Acid 霉酚酸 細(xì)胞代謝抑制劑,24280

Mycophenolic Acid 霉酚酸 細(xì)胞代謝抑制劑,24280

來源:泰然健康網(wǎng) 時(shí)間:2024年12月18日 17:36

跳至內(nèi)容

 Mycophenolic Acid 霉酚酸 細(xì)胞代謝抑制劑:霉酚酸(Mycophenolic Acid,MPA),又名麥可酚酸,是一種免疫抑制劑,用來預(yù)防器管移置后的排斥反應(yīng)。MPA還具有抗真菌、抗細(xì)菌、抗病毒和抗腫瘤效應(yīng)。

Mycophenolic Acid (MPA) 霉酚酸(麥可酚酸)

Mycophenolic Acid (MPA) 霉酚酸;Immunosuppressive Drug 免疫抑制劑;Inosine monophosphatase dehydrogenase次黃嘌呤單核苷酸脫氫酶;IMPDH Inhibitor; Mycophenolate mofetil 嗎替麥考酚酯;CAS NO:24280-93-1;

產(chǎn)品信息

產(chǎn)品名稱 產(chǎn)品編號(hào) CAS NO. 規(guī)格 Mycophenolic Acid (MPA) 霉酚酸(麥可酚酸)

MZ9231-0100MG

24280-93-1

100mg

Mycophenolic Acid (MPA) 霉酚酸(麥可酚酸) MZ9231-1000MG 24280-93-1 1g

霉酚酸(Mycophenolic Acid,MPA),又名麥可酚酸,是一種免疫抑制劑,用來預(yù)防器guan移植后的排斥反應(yīng)。MPA的功能在其是一種有效且可逆的次黃嘌呤單核苷酸脫氫酶(IMPDH)抑制劑,淋巴細(xì)胞中能阻斷GTP的從頭合成并引起RNA和DNA合成的減少,從而防止淋巴細(xì)胞增殖和活化,并抑制抗體生成。MPA還具有抗真菌、抗細(xì)菌、抗病毒和抗腫瘤效應(yīng)。

產(chǎn)品特性

1)   CAS NO:24280-93-1

2)   化學(xué)名:6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid

3)   同義名:MPA; NSC 129185;

4)   分子式:C17H20O6

5)   分子量:320.34

6)   純度:≥98%

7)   外觀:白色或類白色粉末

8)   溶解性:溶于乙醇、甲醇、DMSO(30mg/ml)、不溶于水

注意事項(xiàng)

1)   本霉酚酸(MPA)不是臨床藥物,只能用于科研用途,不能用于診斷或臨床用途。

2)   為了您的安全和健康,請(qǐng)穿實(shí)驗(yàn)服并戴一次性手套操作。

使用方法

文獻(xiàn)1,Azzarone A et al. Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1. Transplant Proc. 1992 Dec;24(6):2868-71. PMID: 1465977

體外研究:

細(xì)胞類型(Cell type):Hepatocytes (from rat liver) in Primary Culture

藥物配制(Preparation):MPA was dissolved in DMSO

實(shí)驗(yàn)方法(Assay):MPA was dissolved in DMSO and added in the appropriate concentrations (0.6, 1.2, 2.4, 5, 10 μg/ml). The amount of DMSO added to the medium was never more than 2 μL/mL, which does not affect hepatocyte proliferation. The in vitro DNA synthesis was detected by [3H] Thymidine Incorporation.

體內(nèi)研究:

動(dòng)物模型(Animal Model):70% partial hepatectomy rat model

藥物配制(Preparation):MPA was dissolved in 0.5% carbossil-methil-cellulose (CMC), 0.4% Tween, and 0.9% alcohol in saline.

注射劑量(Dosages):Rats were assigned to groups and treated for 4 days as controls or with MPA (15mg/kg). On the 4th day, between 0900 and 1030 hours, the rats received a standard 70% hepatectomy under light ether anesthesia. Food and drink were allowed immediay. Twenty-four hours after the hepatectomies, 185 × 10?4 Bq [3H] thymidine was administered to all rats by intraperitoneal injection.

給藥途徑(Administration):Oral (p.o.)

相關(guān)產(chǎn)品

貨號(hào) 名稱 規(guī)格

MZ9231-0100MG

Mycophenolic Acid (MPA) 霉酚酸(麥可酚酸) 100mg

MZ9232-0100MG

Mycophenolate mofetil 嗎替麥考酚酯 100mg

 Mycophenolic Acid 霉酚酸 細(xì)胞代謝抑制劑

Mycophenolic Acid 霉酚酸 細(xì)胞代謝抑制劑

相關(guān)知識(shí)

特別關(guān)注|肝細(xì)胞癌相關(guān)膽汁酸代謝失衡及調(diào)控機(jī)制
山楂酸(Maslinic acid)可抑制骨質(zhì)疏松
免疫抑制劑不良反應(yīng)
武漢大學(xué)揭示脂肪酸代謝調(diào)控內(nèi)胚層分化的分子機(jī)制
喝什么茶能夠抑制脂肪代謝
蔣衛(wèi)團(tuán)隊(duì)揭示脂肪酸代謝調(diào)控內(nèi)胚層分化的分子機(jī)制
促進(jìn)細(xì)胞新陳代謝
體內(nèi)穩(wěn)態(tài)和腫瘤免疫中的T細(xì)胞代謝
Protein & Cell:腸道菌群及其代謝物在代謝性疾病中的作用
營(yíng)養(yǎng)與健康所等發(fā)現(xiàn)衰老細(xì)胞代謝調(diào)控關(guān)鍵機(jī)制

網(wǎng)址: Mycophenolic Acid 霉酚酸 細(xì)胞代謝抑制劑,24280 http://m.u1s5d6.cn/newsview625921.html

推薦資訊